Stomach Cancer Trial, Recruiting NCT06929949 Sponsor: The First Hospital of Jilin University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06929949
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged over 18 and under 75 years old.
  • People who have had a stomach tissue sample (biopsy) taken by camera examination, with results confirming a specific type of stomach cancer or a pre-cancerous growth called an adenoma.
  • People diagnosed with early-stage upper stomach cancer or cancer at the junction of the stomach and food pipe, where the tumour is no larger than 4 cm, as confirmed by scans and tissue testing.
  • People for whom surgery to remove the upper part of the stomach is planned, with the goal of removing all the cancer, and where at least half of the stomach can be left intact.
  • People in good general physical condition, rated 0 or 1 on a standard medical fitness scale (meaning fully active or able to carry out light activity).
  • People assessed as being in a suitable health range for undergoing surgery, rated class I to III on a standard anaesthesia risk scale.
  • People whose liver, kidneys, and other organs are working well enough to tolerate surgery.
  • People who have given written agreement to take part in the trial.

Who may not be able to join:

  • People who have already received radiotherapy, chemotherapy, targeted therapy, or immunotherapy before surgery.
  • People who have more than one cancerous tumour present in the stomach.
  • People who have previously had surgery in the upper abdomen, unless it was keyhole surgery to remove the gallbladder.
  • People who have previously had stomach surgery, unless it was a specific type of endoscopic (camera-based) procedure to treat stomach cancer.
  • People whose scans show the cancer has spread to other parts of the body.
  • People who are pregnant or breastfeeding.
  • People with a history of epilepsy, nervous system conditions, or psychiatric illness that has not been fully controlled.
  • People with a physical disability affecting their limbs or movement.
  • People who have had another type of cancer within the past five years, unless it was a fully treated skin cancer or a very early-stage cervical condition that has been cured.
  • People with serious active heart conditions, such as significant heart failure, certain heart rhythm problems, chest pain from heart disease, or a heart attack within the past six months.
  • People who have had a stroke or bleeding in the brain within the past six months.
  • People with severe infections or other serious health conditions that are not under control.
  • People whose breathing test results show their lung capacity is below 50% of what would normally be expected for someone of their age and size.
  • People who need emergency surgery because of a complication from the tumour, such as bleeding, a tear in the stomach, or a blockage.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15843073207

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The First Hospital of Jilin University
Registry
ClinicalTrials.gov
Start date
25 November 2024
Est. completion
25 November 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of reflux esophagitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov